All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PHVS / Pharvaris N.V.
|
|
|
|
|
|
|
|
/ Apogee Therapeutics, Inc.
|
|
|
|
|
|
|
|
ICVX / Icosavax, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
RYZB / RayzeBio, Inc.
|
|
|
|
|
|
|
|
RZLT / Rezolute, Inc.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TIL / Instil Bio, Inc.
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
SVA / Sinovac Biotech, Ltd.
|
|
|
|
|
|
|
|
QTTB / Q32 Bio Inc.
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
DCTH / Delcath Systems, Inc.
|
|
|
|
|
|
|
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
|
|
|
|
|
ENGN / enGene Holdings Inc.
|
|
|
|
|
|
|
|
SERA / Sera Prognostics, Inc.
|
|
|
|
|
|
|
|
HRMY / Harmony Biosciences Holdings, Inc.
|
|
|
|
|
|
|
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AADI / Aadi Bioscience, Inc.
|
|
|
|
|
|
|
|
CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
IOBT / IO Biotech, Inc.
|
|
|
|
|
|
|
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|